Dechra Pharmaceuticals PLC — Director's Dealing 2013

Feb 26, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7234Y

Dechra Pharmaceuticals PLC

26 February 2013

26 February 2013

Dechra® Pharmaceuticals PLC

("Dechra" or "the Company")

Director / PDMR shareholding

Dechra Pharmaceuticals PLC has been notified that on 26 February 2013 the following transactions in respect of the Company's ordinary shares of 1 pence occurred:

Directors of the Company	Number of shares acquired ("Acquisition")	Price per share of shares acquired (£)	Total number of shares beneficially held following the Acquisition	% of issued share capital beneficially held following the Acquisition
Tony Griffin	8,000	6.84	20,077	0.023%
Julian Heslop	5,000	6.84	5,000	0.006%
Ishbel Macpherson	2,897	6.84	2,897	0.003%

For further information, please contact:

Zoe Goulding, Company Secretary            

Telephone number: 01782 771100

About Dechra

Dechra is an international veterinary pharmaceutical business.  Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSNKADKABKDPBB